♟️ Monday 17 November 2025 Mon, 17 Nov 2025

RPMGlobal shareholders are set to vote on Caterpillar’s $5.00 per share acquisition proposal following Federal Court approval to convene a Scheme Meeting. The Independent Expert deems the offer fair and reasonable, with the RPM Board unanimously backing the deal.

Shriro Holdings reported a 13.6% revenue decline in FY25 amid a strategic shift in its BBQ segment but delivered a 5.5% rise in EBITDA. The company plans a $20 million share buy-back in FY26, signaling confidence in its operational turnaround.

Livium Ltd has locked in exclusive worldwide rights to a cutting-edge microwave technology from the University of Melbourne, promising high recovery rates and energy savings in rare earth and platinum group metals extraction.

Energy Transition Minerals has taken a decisive legal step by asking Greenland’s High Court to remove Denmark from its rare earth project dispute, paving the way for substantive hearings on its exploitation licence claim.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Genmin Limited has launched a A$25.7 million equity raising to advance its Baniaka iron ore project in Gabon, aiming for a final investment decision by mid-2026. The raise includes strategic collaboration with PowerChina and offers attaching options to investors.

Genmin Limited has locked in A$25.7 million through a two-tranche placement, including significant director loan conversions, to advance its flagship Baniaka iron ore project towards production.

Critica Limited has raised A$8 million in an oversubscribed placement to accelerate development of its Jupiter rare earths project, positioning itself as a key supplier of critical minerals for emerging technologies.

AnteoTech has achieved a breakthrough with its Ultranode™ X anode surpassing 1,000 charge cycles at 80% capacity retention, meeting key benchmarks for electric vehicle and eVTOL batteries. This milestone leverages cost-effective silicon materials, promising to reshape supply chains and accelerate market adoption.

Virgin Money UK, trading as Clydesdale Bank, has applied to the High Court for approval to transfer its entire banking business to Nationwide Building Society, pending a February 2026 hearing.

Island Pharmaceuticals has secured FDA confirmation that its antiviral Galidesivir can proceed under the Animal Rule pathway for Marburg virus, qualifying for a lucrative Priority Review Voucher. This regulatory milestone accelerates the drug’s path to approval and potential government stockpile inclusion.

Diablo Resources has appointed Matthew Blumberg as a Non-Executive Director and brought on Ellis Martin as its U.S. Media and Investor Communications Advisor, signaling a strategic push into North American markets.

Algorae Pharmaceuticals has launched a Loyalty Options Offer, allowing eligible shareholders to purchase options at a nominal price, aiming to reward loyalty and support future growth funding.

Race Oncology has announced pivotal new clinical trials for its lead asset RC220, aiming to accelerate regulatory approval in Acute Myeloid Leukemia and tackle resistance in Non-Small Cell Lung Cancer.

Orcoda Limited announces a pivotal leadership transition with Patrick Bodegraven stepping in as Managing Director, while long-serving Geoff Jamieson shifts to a part-time CFO role to support continuity.

Energy World Corporation Ltd has outlined a strategic reset including a $442 million debt-to-equity conversion and is progressing towards commissioning its flagship Pagbilao LNG and power project in the Philippines, alongside advancing its Sengkang LNG facility in Indonesia.

Elders Limited reported a solid FY25 with a 12% rise in profit after tax to $50.3 million, completing the strategic acquisition of Delta Agribusiness and advancing key operational and sustainability initiatives.

Calix Limited has secured a pivotal $35 million joint development agreement with Rio Tinto to advance its Zesty Green Iron Demonstration Plant in Western Australia, backed by a substantial ARENA grant. This collaboration aims to pioneer low-emission steel production using innovative hydrogen and electric heating technology.

Genetic Signatures Limited unveiled a year of strategic transformation and robust financial growth at its 2025 AGM, highlighting leadership renewal and a sharpened commercial focus. The company’s FY25 revenue jumped 66%, driven by strong product demand and expanded market presence.

Augustus Minerals has applied for a significant exploration licence in Papua New Guinea’s Vanapa River region, positioning itself within one of the world’s richest gold-copper belts while progressing its Mt Kare project.

White Cliff Minerals has significantly expanded the Danvers 1 copper mineralisation footprint at its Rae Copper Project in Nunavut, Canada, more than doubling strike length and confirming mineralisation beyond 400 metres depth. This milestone sets the stage for a maiden JORC resource in 2026 and highlights promising regional exploration potential.

Adavale Resources has uncovered significant resource growth potential at its London-Victoria gold deposit through historic data recovery and a new structural geology study, setting the stage for an imminent drilling campaign.

Prominence Energy Ltd has made significant technical progress at its Gawler Hydrogen Project, confirming high-grade natural hydrogen potential and preparing for a major geochemical survey in early 2026. The company also strengthens its global position by joining a prestigious hydrogen delegation to Korea.

5E Advanced Materials reports progress on its California boron project with a new feasibility study and equity raises, while highlighting ongoing funding uncertainties.